Charles Linker
Impact in
- Hematology top 1%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 39
- Hematopoietic Stem Cell Transplantation 18
- Acute Myeloid Leukemia Research 15
- Chronic Myeloid Leukemia Treatments 9
- Multiple Myeloma Research and Treatments 6
- Oncology 19
- CAR-T cell therapy research 6
- Co-authors
- Curt A. Ries (7 shared papers)Lloyd E. Damon (20 shared papers)Michael W. DeGregorio (3 shared papers)Richard A. Jacobs (2 shared papers)William M. F. Lee (1 shared paper)Richard M. Stone (4 shared papers)Richard A. Larson (6 shared papers)John P. Huberty (2 shared papers)
- Journals
- Blood (18 papers)Biology of Blood and Marrow Transplantation (12 papers)Journal of Clinical Oncology (4 papers)Cancer Chemotherapy and Pharmacology (4 papers)Leukemia Research (3 papers)
- Partner nations
- United StatesCanadaPanama
In The Last Decade
Charles Linker
57 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 91
- Hematology 908
- Genetics 304
- Oncology 612
- Public Health, Environmental and Occupational Health 434
- Immunology 316
Countries citing papers authored by Charles Linker
This map shows the geographic impact of Charles Linker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Linker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Linker more than expected).
Fields of papers citing papers by Charles Linker
This network shows the impact of papers produced by Charles Linker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Linker. The network helps show where Charles Linker may publish in the future.
Co-authors
The 25 scholars most cited alongside Charles Linker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1982 | 321 | |
| 2 | 1998 | 208 | |
| 3 | 2009 | 186 | |
| 4 | 2002 | 159 | |
| 5 | 2009 | 142 | |
| 6 | 2011 | 110 | |
| 7 | 2015 | 106 | |
| 8 | 2006 | 104 | |
| 9 | 2009 | 85 | |
| 10 | 2006 | 75 | |
| 11 | 2000 | 72 | |
| 12 | 2011 | 53 | |
| 13 | 2011 | 47 | |
| 14 | 2000 | 46 | |
| 15 | 2001 | 41 | |
| 16 | 1986 | 39 | |
| 17 | 2006 | 31 | |
| 18 | 2008 | 29 | |
| 19 | 1986 | 29 | |
| 20 | 1985 | 28 |
About Charles Linker
Charles Linker is a scholar working on Hematology, Oncology, Genetics, Public Health, Environmental and Occupational Health and Pathology and Forensic Medicine, having authored 58 papers that have together received 2.2k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (18 papers), Acute Myeloid Leukemia Research (15 papers), Chronic Lymphocytic Leukemia Research (11 papers), Acute Lymphoblastic Leukemia research (10 papers), Chronic Myeloid Leukemia Treatments (9 papers), CAR-T cell therapy research (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Multiple Myeloma Research and Treatments (6 papers). The work is most often cited by research in Hematology (908 citations), Genetics (304 citations), Oncology (612 citations), Public Health, Environmental and Occupational Health (434 citations) and Immunology (316 citations). Charles Linker has collaborated with scholars based in United States, Canada and Panama. Frequent co-authors include Curt A. Ries, Lloyd E. Damon, Michael W. DeGregorio, Richard A. Jacobs, William M. F. Lee, Richard M. Stone, Richard A. Larson, John P. Huberty, Paul A. FitzGerald and David C. Price. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.